Eye tests for people taking Tivdak for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial is for people with cervical cancer that has come back or spread and is getting worse after chemotherapy. It will check your eyes regularly while you take Tivdak to see how the drug affects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has come back or spread and it got worse after chemotherapy.
- Your doctor has decided that Tivdak is the right treatment for you.
- You are willing to have several eye exams and regular clinic visits.
- You agree to use effective birth control if needed.
- You have not taken Tivdak before.
- You do not have any active eye disease right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new drug called IBI3031 to treat active thyroid eye disease (TED), a condition where the immune system attacks muscles and tissue around the eyes, causing swelling, bulging, and sometimes double vision. The study aims to see if this drug can reduce inflammation and improve symptoms.
This study collects information and eye health data from people who have had cancer treatment, including stem cell transplants. It helps doctors understand how cancer therapies affect the eyes over time.
This trial tests a medication called IBI311 for people with inactive thyroid eye disease that still causes bothersome symptoms like double vision or trouble closing the eyes. The goal is to see if it helps improve these problems safely.
This study tests an investigational medication for thyroid eye disease, which causes bulging eyes and discomfort. The treatment is given as an injection near the eye, and the study will last about 12 months to see how safe and effective it is.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
This trial tests a new drug called SCTT11 in healthy people and in those with thyroid eye disease (TED) to see if it is safe and helpful. It may be an option if you have moderate-to-severe TED that affects your daily life.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.